The allergy diagnostic market is experiencing strong growth as the global prevalence of allergic disorders continues to increase. The market is projected to reach USD 10.77 billion by 2031, up from USD 6.80 billion in 2026, registering a CAGR of 9.6% during the forecast period.
The growing prevalence of allergic rhinitis, asthma, atopic dermatitis, food allergies, and other allergic conditions is increasing the demand for accurate and timely diagnostic testing. Rising urbanization, pollution, changing lifestyles, and genetic susceptibility are contributing to the growing burden of allergic diseases worldwide.
At the same time, advances in immunoassays, molecular diagnostics, comprehensive allergen panels, and point-of-care testing are creating new opportunities for diagnostic companies and laboratories.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=232871701
Allergy Diagnostic Market Overview
Allergy diagnostics play an important role in identifying specific allergens responsible for allergic reactions. Accurate testing enables healthcare professionals to distinguish between different allergens and develop more targeted management strategies.
Allergy testing can help identify sensitivities to substances such as pollen, foods, dust mites, animal dander, and other environmental allergens. The results can support allergen avoidance, immunotherapy, and personalized treatment decisions.
The growing demand for precise diagnosis is also helping reduce reliance on trial-and-error approaches to allergy management. This is particularly important for patients with multiple allergies or persistent symptoms.
Key Growth Drivers of the Allergy Diagnostic Market
Rising Prevalence of Allergic Disorders
The increasing prevalence of allergic diseases is one of the primary factors driving the allergy diagnostic market.
Allergic rhinitis, asthma, atopic dermatitis, and food allergies affect populations across different age groups and geographic regions. Environmental pollution, urbanization, changing lifestyles, and genetic factors are contributing to the increasing incidence of allergic disorders.
As the number of patients requiring diagnosis increases, healthcare providers are demanding reliable testing technologies that can identify specific allergens.
Increasing Demand for Accurate Allergy Testing
Patients and clinicians are increasingly seeking diagnostic tests that provide more comprehensive and accurate information.
Traditional approaches based primarily on symptoms may not always identify the specific allergen responsible for a reaction. Advanced allergy diagnostics can provide more detailed information regarding IgE sensitivity to individual allergens.
This information can help clinicians recommend appropriate management strategies and improve patient care.
Growing Food Allergy Awareness
Food allergies are becoming an important area of focus, particularly among children.
Increasing awareness of food allergies is encouraging pediatric departments and healthcare providers to use diagnostic testing to identify specific food sensitivities. Accurate diagnosis can help prevent unnecessary long-term dietary restrictions that could contribute to nutritional deficiencies.
This growing focus on pediatric allergy management is expected to support demand for allergy diagnostic products and services.
Increasing Environmental Pollution and Urbanization
Rapid urbanization and increasing exposure to air pollutants are contributing to the growing burden of respiratory and allergic disorders.
Higher exposure to pollutants and changing environmental conditions can increase the risk of allergic symptoms and respiratory complications. As a result, demand for allergy screening and diagnostic services is expected to increase in urban populations.
Advanced Diagnostics Are Transforming Allergy Testing
The allergy diagnostic industry is moving toward more comprehensive and technologically advanced testing solutions.
Molecular Allergy Diagnostics
Molecular diagnostics can provide detailed information about sensitization to specific allergen components.
This approach can help clinicians differentiate between genuine sensitization and cross-reactivity, supporting more personalized allergy management.
Comprehensive Allergen Panels
The demand for broader allergen panels is increasing as clinicians seek to evaluate patients with multiple or complex allergies.
Comprehensive testing can provide information on multiple potential allergens in a single diagnostic workflow, improving testing efficiency.
Immunoassay-Based Testing
Immunoassays remain an important technology in allergy diagnostics. These tests can detect specific immunoglobulin E (IgE) antibodies associated with allergic sensitization.
Continued improvements in assay sensitivity, automation, and laboratory workflows are supporting the expansion of immunoassay-based allergy testing.
Point-of-Care Allergy Testing
The growing interest in decentralized healthcare is creating opportunities for point-of-care allergy diagnostics.
Rapid testing technologies can potentially improve accessibility and shorten turnaround times, particularly in settings where centralized laboratory infrastructure is limited.
Regional Growth Opportunities
The allergy diagnostic market is supported by growing demand across developed and emerging economies.
Regions with high pollen exposure and significant seasonal allergy populations are expected to generate substantial demand for allergy screening and management.
At the same time, emerging economies are expanding laboratory infrastructure and improving access to diagnostic services. Increasing healthcare expenditure and growing awareness of allergic diseases are creating opportunities for both multinational and regional diagnostic companies.
Asia Pacific is particularly important because of its large population, expanding healthcare infrastructure, increasing awareness of allergic disorders, and growing diagnostic capabilities in countries such as China and India.
Competitive Landscape of the Allergy Diagnostic Market
The allergy diagnostic market is highly competitive, with major players investing in product development, portfolio expansion, partnerships, and geographic expansion.
Prominent companies include Thermo Fisher Scientific, Siemens Healthineers, Danaher, Minaris Medical America, Omega Diagnostics Group, bioMérieux, Romer Labs, EUROIMMUN, HollisterStier Allergy, Eurofins Scientific, Stallergenes Greer, HOB Biotech Group, HYCOR Biomedical, R-Biopharm, AESKU.GROUP, ACON Laboratories, Lincoln Diagnostics, Astra Biotech, Erba Group, Alcit India, Biopanda Reagents, Bioside, Creative Diagnostic Medicare, DST Diagnostische Systeme & Technologien, and Dr. Fooke Laboratorien, among others.
Companies are focusing on improving assay performance, expanding testing menus, developing compact analyzers, strengthening distribution networks, and increasing access to allergy testing.
Key Players in the Allergy Diagnostic Market
Thermo Fisher Scientific
Thermo Fisher Scientific maintains a strong position in allergy diagnostics through its Phadia portfolio of allergy testing instruments and solutions.
The company’s broad product portfolio and extensive global presence support its position among leading allergy diagnostic providers. Its customer base spans pharmaceutical and biotechnology companies, hospitals, clinical laboratories, universities, research institutions, and other organizations.
Danaher
Danaher participates in the allergy diagnostic market through its diagnostic businesses, including Beckman Coulter.
The company provides laboratory instruments, consumables, and testing solutions used across clinical diagnostic environments. Its broad Core Lab Diagnostics portfolio enables it to serve hospitals, outpatient facilities, physicians’ offices, and other healthcare settings.
Siemens Healthineers
Siemens Healthineers has strengthened its immunodiagnostics capabilities to address increasing demand for laboratory-based allergy testing.
The company’s focus includes expanding assay menus, improving analyzer throughput, laboratory automation, and digital connectivity. These technologies can help laboratories manage growing testing volumes while improving workflow efficiency.
Market Ranking
The leading companies account for a significant portion of the global allergy diagnostic market. Major players include Thermo Fisher Scientific, Siemens Healthineers, Danaher, Revvity through EUROIMMUN, and Canon through Minaris Medical America, among others.
The competitive environment includes both multinational companies and regional manufacturers.
Regional manufacturers, particularly in Asia Pacific, are strengthening their positions by expanding immunoassay kits, consumables, compact analyzers, and other diagnostic products. Improvements in assay accuracy, turnaround time, regulatory compliance, and pricing are helping regional companies compete more effectively.
Future Trends in the Allergy Diagnostic Market
Shift Toward Personalized Allergy Management
Personalized medicine is expected to influence the future of allergy diagnostics. More detailed diagnostic information can help clinicians develop individualized approaches to allergy management.
Growth of Molecular Testing
Molecular allergy testing is expected to remain an important area of innovation as clinicians seek more detailed information about allergen components and cross-reactivity.
AI and Digital Diagnostics
Artificial intelligence and digital technologies could support image interpretation, diagnostic workflows, data management, and clinical decision support.
Expansion of Point-of-Care Testing
The development of rapid and compact diagnostic technologies could expand access to allergy testing outside traditional centralized laboratories.
Increasing Pediatric Allergy Testing
Growing awareness of food allergies and other childhood allergic disorders is expected to increase demand for pediatric diagnostic services.
Expansion in Emerging Markets
Improving healthcare infrastructure, rising healthcare expenditure, and growing awareness of allergic diseases are expected to create significant opportunities in emerging economies.
Opportunities for Market Participants
The growth of the allergy diagnostic market creates opportunities across the healthcare value chain.
Diagnostic manufacturers can focus on developing highly sensitive assays, molecular diagnostic technologies, compact analyzers, and comprehensive allergen panels.
Laboratories can expand specialized allergy testing services and adopt automated diagnostic platforms.
Point-of-care manufacturers can target decentralized healthcare settings with rapid and easy-to-use testing solutions.
Healthcare providers can benefit from improved diagnostic accuracy and more personalized approaches to allergy management.
Emerging markets also offer opportunities for companies capable of providing affordable, accessible, and reliable allergy testing technologies.
Conclusion
The allergy diagnostic market is projected to grow from USD 6.80 billion in 2026 to USD 10.77 billion by 2031, at a CAGR of 9.6%.
The increasing prevalence of allergic rhinitis, asthma, atopic dermatitis, food allergies, and other allergic conditions is creating sustained demand for accurate diagnostic solutions. Growing awareness, increasing healthcare expenditure, and the need to reduce trial-and-error treatment approaches are further supporting market expansion.
Meanwhile, molecular diagnostics, comprehensive allergen panels, immunoassays, point-of-care testing, AI-enabled diagnostics, and digital laboratory solutions are expected to shape the future of the industry.
As healthcare systems increasingly move toward personalized and preventive care, the demand for precise allergy diagnostics is expected to remain strong, creating attractive opportunities for diagnostic manufacturers, laboratories, healthcare providers, and technology companies.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=232871701
Frequently Asked Questions
What is the allergy diagnostic market size?
The global allergy diagnostic market is projected to reach USD 10.77 billion by 2031, up from USD 6.80 billion in 2026.
What is the CAGR of the allergy diagnostic market?
The market is expected to grow at a CAGR of 9.6% from 2026 to 2031.
What is driving the growth of the allergy diagnostic market?
Key factors include the rising prevalence of allergic disorders, increasing awareness, urbanization, pollution, growing healthcare expenditure, and demand for accurate and personalized diagnostic testing.
What are the major types of allergy diagnostics?
Major approaches include immunoassays, molecular allergy diagnostics, allergen-specific IgE testing, comprehensive allergen panels, and point-of-care testing.
Who are the major companies in the allergy diagnostic market?
Major companies include Thermo Fisher Scientific, Siemens Healthineers, Danaher, Revvity, Canon, bioMérieux, EUROIMMUN, and Omega Diagnostics, among others.
How is molecular diagnostics influencing allergy testing?
Molecular diagnostics can provide more detailed information about allergen components and sensitization patterns, supporting more personalized allergy management.
What are the future trends in allergy diagnostics?
Key trends include molecular testing, personalized allergy management, AI and digital diagnostics, point-of-care testing, comprehensive allergen panels, and expansion into emerging markets.
